5th Cardio-Rheumatology Virtual Symposium
On June 16, an international team of experts will discuss the latest evidence on the management of rheumatic patients at higher risk of cardiovascular disease. This symposium will include in-depth information linking rheumatic and cardiovascular diseases, and a practical guide for optimizing metabolic health, treatment and prevention of cardiovascular events.
The event features a global series of speakers, with question and answer sessions and panel discussions spread throughout the day. Delivered fully online, this year's symposium will be accessible to attendees internationally. Information, including login credentials, will be emailed to registrants beginning one week prior to the event date (please ensure that you register with a valid email address).
Features of the online format include:
- A customized digital conference platform
- Live interaction during plenary sessions and panel discussion
- Networking with attendees via text and video conferencing
- Access to recorded sessions and content for 6 months following the event
To download and share the full program brochure (as seen below), click here
CME Accreditation Statement:
The Cardio-Rheumatology Symposium is an accredited group learning activity, as defined by Continuing Professional Development, Temerty Faculty of Medicine, University of Toronto. A Certificate of Accreditation will be issued to registrants upon conclusion of the event. Participants may claim hours of credit under the following certification programs:
- College of Family Physicians of Canada - Mainpro+ Group Learning
- Royal College of Physicians and Surgeons of Canada – Section 1
- American Medical Association - AMA PRA Category 1
- European Union for Medical Specialists UEMS-EACCME®
About Us:
This event is organized by the Cardio-Rheumatology Network, a collaboration among clinicians and scientists within the Temerty Faculty of Medicine, University of Toronto. Established in 2017, the Cardio-Rheum Network aims to improve the primary prevention of cardiovascular events in rheumatic patients by developing novel approaches to risk stratification using traditional risk factors, laboratory biomarkers and cardiovascular imaging. For more information, visit our website: www.cardiorheum.org